Hovione to create new campus and 100 jobs at New Jersey site

The new 31,000-sq. ft building will bring additional commercial spray drying capacity for customers who favour US-based manufacturing

Spray drying and particle engineering specialist Hovione has announced it is expanding its facilities at its East Windsor, New Jersey site with the creation of a state-of-the-art Hovione Campus.

The new 31,000-sq. ft (2900m2) building will be next to the company's existing site in New Jersey, laying the foundations of a Hovione Campus, and will bring additional commercial spray drying capacity online by 2023.

It will also allow the company to respond to customers favouring US-based manufacturing, from development all the way to commercial.

According to Hovione, the increased capacity will solidify its integrated offer ― API, particle engineering, drug product ― in the region.

The expansion, which was announced during CPhI Worldwide, in Milan, by Guy Villax, CEO, and Jean-Luc Herbeaux, COO, forms part of the company's $170 million global expansion strategy to increase capacity at its sites in the US, Ireland and Portugal leading to a global capacity increase of approximately 25%. The increased capacity will also create up to 100 jobs during the course of the next few years.

Filipe Tomás, General Manager at Hovione in New Jersey described the US market as "fundamental for the company" and this investment as "a key step in our expansion strategy".

ABOUT HOVIONE

Hovione has over 60 years of experience as a CDMO and is a specialized integrated supplier offering services for drug substance, drug product intermediate and drug product. With four FDA inspected sites in the USA, China, Ireland and Portugal and development laboratories in Portugal and USA, the company provides branded pharmaceutical customers services for the development and compliant manufacture of innovative drugs including highly potent compounds. 
Hovione offers a full range of development services and manufacturing capacity in particle engineering (Spray Drying, Spray Congealing, Hot Melt Extrusion, Jet Milling, Nanoparticles and Wet Polishing) to provide optimal solutions for your drug product with the right scale and flexibility. 
For generic pharmaceutical customers the company offers niche API products. Hovione also provides proprietary product development and licensing opportunities for drug products. 
In the inhalation area, Hovione is the only independent company offering a complete range of services.